Jones Day‘s venture and capital growth practice advises clients across every stage of development, from entrepreneurial start-ups to multinational corporations. The team is particularly well regarded for its work with technology and biotechnology companies, as well as the financial and industrial strategic investors who finance them. The practice is led by a group of seasoned private equity and M&A specialists including Renaud Bonnet, Charles Gavoty, Jean-Gabriel Griboul, Anne Kerneur, Geoffroy Pineau-Valencienne, and Alexandre Wibaux who divides his time between New York and Paris.
\n
\n
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Jones Day distinguishes itself from its competitors through the quality of its services. High-quality legal advice and added value, support during negotiations, an approach that combines high standards with pragmatism and impeccable responsiveness.'
- ‘Jones Day offers advice on several complex topics in a perfectly coordinated manner. The partner in charge of our projects briefed his colleagues before our discussions, saving us considerable time at each stage of our projects. Jones Day's expertise in Venture Capital and BSPCEs seemed particularly robust, allowing us to skillfully negotiate the shareholders' agreement and BSPCE plans.'
- ‘Jean-Gabriel Griboul brings experience in fundraising, is easy to work with and has a pragmatic approach to problem-solving and negotiation.'
Key clients
- Elaia Partners
- Ankaa Ventures
- Bioptimus
- Shippeo
- Electric Motion
- Bpifrance
- CVE Biogaz
- Partech Partners
- Alven
- ETF Partners
- Seventure Partners
- Vsora
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Other key lawyers
Renaud Bonnet, Charles Gavoty, Jean-Gabriel Griboul, Anne Kerneur, Geoffroy Pineau-Valencienne, Alexandre Wibaux